|transkript 3/2022 is here!
|transkript, one of our German magazines, has been the leading industry publication for biotechnology and life sciences in German-speaking Europe since 1995. It covers current information, opinions, and background on business, research, and politics.
In this issue:
Who Will Unlock the Data Treasure?
Biotech nations like the USA, the UK, and Scandinavian countries are already leveraging the integration of patient care data with sequencing and biobank information. In September, German Health Minister Karl Lauterbach plans to unveil a strategy. An exclusive interview with Klaus Holetschek, Bavaria’s State Minister for Health and Care, offers further insights.What’s Happening at Biofrontera?
Even a 25th anniversary isn’t a guarantee against existential challenges. What’s next for Biofrontera AG of Leverkusen? Key figures at this crossroads include founder Hermann Lübbbert and activist supervisory board chairman Wilhelm K.T. Zours, locked in yet another (or still the same?) intense battle.
Even a 25th anniversary isn’t a guarantee against existential challenges. What’s next for Biofrontera AG of Leverkusen? Key figures at this crossroads include founder Hermann Lübbbert and activist supervisory board chairman Wilhelm K.T. Zours, locked in yet another (or still the same?) intense battle.
More topics:
- COVID-19: Politicians and mRNA vaccine developers aim to ease the autumn wave with Omicron-specific vaccines, but two research groups are already working on a solution to stop SARS-CoV-2 infection altogether.
- CO2: Biotech’s role in reducing CO2 emissions is often overlooked. The INDUSTRIA BIOTEC event in October in Berlin highlights the sector’s contributions.
- Alzheimer’s: Is the Amyloid Beta hypothesis for Alzheimer’s at a dead end? A clinical trial delivers both disappointment and fresh insights.
Transkript-Spezial: BIO-Europe and Financing
- Industry Optimism: Interview with the BVMA board
- Biotech Bonanza: An abrupt end to the boom
LABORWELT-Spezial: Cell and Gene Therapies
- Gene Therapy: New vectors emerge
- Interview with Dr. Rob Panting, Rentschler ATMP, Stevenage
- Zynteglo: Gene therapy’s cost record
- New Products: Diagnostics-4-Future
- Interview with Dr. Bernd Block, Trumpf Laser & Systemtechnik
- Five Steps to a DIGA (Digital Health Application)
- Monitoring Lung Function with a wearable vest
- Medtech-Inside: Financial insights column
- Start-ups at the forefront